scholarly journals Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease

Gut Microbes ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 1-18
Author(s):  
Yizhong Wang ◽  
Xuefeng Gao ◽  
Xinyue Zhang ◽  
Fangfei Xiao ◽  
Hui Hu ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Infliximab Therapy

Improvement of bone metabolism after infliximab therapy in Crohn's disease

2004 ◽  
Vol 42 (05) ◽  
Author(s):  
P Miheller ◽  
G Mûzes ◽  
T Zágoni ◽  
M Tóth ◽  
Z Tulassay
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Bone Metabolism ◽  
Infliximab Therapy

Long-term management of resistant, fistulazing Crohn's disease by ongoing 4-weekly infliximab therapy (a case report)

2005 ◽  
Vol 43 (05) ◽  
Author(s):  
R Schwab ◽  
P Lakatos ◽  
E Schäfer ◽  
J Weltner ◽  
A Sáfrány ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Case Report ◽  
Crohn's Disease ◽  
Infliximab Therapy ◽  
Term Management

Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response

2008 ◽  
Vol 31 (7) ◽  
pp. 421-426 ◽  
Author(s):  
Yago González-Lama ◽  
Antonio López-San Román ◽  
Ignacio Marín-Jiménez ◽  
Begoña Casis ◽  
Isabel Vera ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Multicenter Study ◽  
Infliximab Therapy ◽  
Open Label ◽  
Predictors Of Response
Sign in / Sign up

Export Citation Format

Share Document